Search

Your search keyword '"Narunsky K"' showing total 27 results

Search Constraints

Start Over You searched for: Author "Narunsky K" Remove constraint Author: "Narunsky K"
27 results on '"Narunsky K"'

Search Results

1. Drug interaction potential of high-dose rifampicin in patients with pulmonary tuberculosis.

3. High-dose rifampicin, Moxifloxacin, and SQ109 for Treating Tuberculosis: A Multi-arm, Multi-stage Randomised Controlled Trial

4. A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis

5. Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients

6. A Step toward an Optimized Rifampin Dose Completed.

9. Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.

10. Safety, pharmacokinetics, and early bactericidal activity of quabodepistat in combination with delamanid, bedaquiline, or both in adults with pulmonary tuberculosis: a randomised, active-controlled, open-label trial.

11. Drug interaction potential of high-dose rifampicin in patients with pulmonary tuberculosis.

12. Phase I Single Ascending Dose and Food Effect Study in Healthy Adults and Phase I/IIa Multiple Ascending Dose Study in Patients with Pulmonary Tuberculosis to Assess Pharmacokinetics, Bactericidal Activity, Tolerability, and Safety of OPC-167832.

13. Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-Containing Regimens for Drug-Sensitive Tuberculosis: 12-Week Results.

14. High Prevalence of Tuberculosis Infection and Disease in Child Household Contacts of Adults With Rifampin-resistant Tuberculosis.

15. Resistance to Mycobacterium tuberculosis Infection Among Household Contacts: A Multinational Study.

16. Increased bactericidal activity but dose-limiting intolerability at 50 mg·kg -1 rifampicin.

17. Central monitoring in a randomized, open-label, controlled phase 3 clinical trial for a treatment-shortening regimen for pulmonary tuberculosis.

18. Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial.

19. Pretomanid Pharmacokinetics in the Presence of Rifamycins: Interim Results from a Randomized Trial among Patients with Tuberculosis.

21. Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis.

22. High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.

23. A Step toward an Optimized Rifampin Dose Completed.

24. Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients.

25. A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.

26. Phase II dose-ranging trial of the early bactericidal activity of PA-824.

27. Early bactericidal activity and pharmacokinetics of PA-824 in smear-positive tuberculosis patients.

Catalog

Books, media, physical & digital resources